Kirin (OTCMKTS:KNBWY) Shares Gap Down – What’s Next?

Kirin Holdings Co. (OTCMKTS:KNBWY) shares gapped down before the market opened on Wednesday. The stock had previously closed at $19.69, but opened at $18.75. Kirin shares last traded at $18.75, with a volume of 27,293 shares.

Analyst Ratings Changes

Separately, Zacks Research raised shares of Kirin from a “strong sell” rating to a “hold” rating in a research report on Tuesday, September 29th. One research analyst has rated the stock with a Hold rating. Based on data from MarketBeat.com, the company has an average rating of “Hold”.

Kirin Price Performance

The firm has a market capitalization of $15.48 billion, a price-to-earnings ratio of 12.39 and a beta of 0.05. The company has a fifty day moving average price of $18.40 and a two-hundred day moving average price of $17.39. The company has a quick ratio of 1.02, a current ratio of 1.48 and a debt-to-equity ratio of 0.48.

Kirin (OTCMKTS:KNBWY) last posted its quarterly earnings data on Wednesday, November 11th. The company reported $0.36 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.09. The company had revenue of $3.99 billion for the quarter, compared to analyst estimates of $4.04 billion. Kirin had a net margin of 7.58% and a return on equity of 11.54%. On average, equities research analysts expect that Kirin Holdings Co. will post 1.32 EPS for the current fiscal year.

Kirin Company Profile

Kirin Holdings Company, Limited is a Japanese company with businesses in beverages, pharmaceuticals and health science. Its beverage operations include beer, wine, spirits, soft drinks and other nonalcoholic products, with brands sold in Japan and international markets. The company traces its roots to the Japan Brewery Company, established in 1885, and adopted the Kirin Brewery name in 1907. Today, its pharmaceutical business includes Kyowa Kirin, which develops and sells medicines, while its health science activities include products such as supplements and functional foods.